CASP3 and acute lymphoblastic leukemia: Another study proposed that c-MYC inhibition sensitizes acute lymphoblastic leukemia (ALL) to chemotherapy by altering caspase-3-dependent apoptosis and autophagy by targeting the PI3K pathway [66].